Sagimet ' s Shares Hit New High as Fatty Liver Disease Drug Shows Promise in Study Sagimet ' s Shares Hit New High as Fatty Liver Disease Drug Shows Promise in Study

Sagimet Biosciences said on Monday its experimental drug to treat a fatty liver disease significantly reduced the symptoms in a mid-stage study, sending the drug maker ' s...Reuters Health Information
Source: Medscape Internal Medicine Headlines - Category: Internal Medicine Tags: Gastroenterology Source Type: news